Samsung Bioepis switches gears, moves from knockoffs to new drugs with fast-changing Takeda
Samsung Bioepis knows how to make a great copy of a biologic. Now the company wants to start creating them from scratch.
The biosimilars maker …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
